AbbVie Inc. (ABBV)

• Annual Data
• Quarterly Data

AbbVie Inc., common-size consolidated income statement

	12 months ended	Dec 31, 2018		Dec 31, 2017		Dec 31, 2016		Dec 31, 2015		Dec 31, 2014
	Net revenues
	Cost of products sold
	Gross margin
	Selling, general and administrative
	Research and development
	Acquired in-process research and development
	Other expense
	Operating earnings
	Interest expense
	Interest income
	Interest expense, net
	Net foreign exchange loss
	Other income (expense), net
	Earnings before income taxes
	Income tax (expense) benefit
	Net earnings

Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20).